Key signaling pathways affected by miR‐21 include EMT, androgen receptor (AR) signaling, estrogen receptor (ER) signaling, RAS/MAPK, RTK, and mTOR/TSC pathways, all of which are vital in breast cancer progression. This evidence concerns the gene MTOR and breast carcinoma.